Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-077638
Filing Date
2015-11-10
Accepted
2015-11-10 16:04:26
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-18042_110q.htm 10-Q 1117419
2 EX-31.1 a15-18042_1ex31d1.htm EX-31.1 11162
3 EX-31.2 a15-18042_1ex31d2.htm EX-31.2 11202
4 EX-32.1 a15-18042_1ex32d1.htm EX-32.1 5254
5 EX-32.2 a15-18042_1ex32d2.htm EX-32.2 5252
  Complete submission text file 0001104659-15-077638.txt   4213106

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT derm-20150930.xml EX-101.INS 808146
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT derm-20150930.xsd EX-101.SCH 35163
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT derm-20150930_cal.xml EX-101.CAL 39460
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT derm-20150930_def.xml EX-101.DEF 103559
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT derm-20150930_lab.xml EX-101.LAB 347451
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT derm-20150930_pre.xml EX-101.PRE 219703
Mailing Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025
Business Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025 650 421 7200
Dermira, Inc. (Filer) CIK: 0001557883 (see all company filings)

EIN.: 273267680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36668 | Film No.: 151218894
SIC: 2834 Pharmaceutical Preparations